ID

12175

Descripción

A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation NCT00148148

Palabras clave

Versiones (2)
  1. 6/10/15 6/10/15 -
  2. 6/10/15 6/10/15 - Martin Dugas
Subido en

6 de octubre de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0 Legacy
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Inclusion and exclusion criteria Stem-Cell Transplantation CASLAMB NCT00148148

Alemán Inglés

Inclusion and exclusion criteria Stem-Cell Transplantation CASLAMB NCT00148148

1 formularios  
Inclusion criteria
Descripción

Inclusion criteria

Alias
UMLS CUI-1
C1512693
Adult Patient (>=18 years) with granulocytopenia (absolute number neutrophil: <=500 / ul) and allogeneic hematopoietic condition after Stem cell transplantation and immunosuppression with cyclosporine A
Descripción

Adult Patient (≥ 18 years) with granulocytopenia (absolute number neutrophil: ≤500 / μl) and allogeneic hematopoietic condition after Stem cell transplantation and immunosuppression with cyclosporine A

Tipo de datos

boolean

Patient with persistent or relapsed fever (oral temperature ≥38.0°C) and granulocytopenia (absolute Neutrophil Count ≤500 / μl) and adequate antibacterial therapy for ≥36-48 Hours in need of empirical antifungal therapy A
Descripción

Patient with persistent or relapsed fever (oral temperature ≥38.0°C) and granulocytopenia (absolute Neutrophil Count ≤500 / μl) and adequate antibacterial therapy for ≥36-48 Hours in need of empirical antifungal therapy A

Tipo de datos

boolean

Reclining, at least double-recurrent central venous catheters for administration of drugs and for the extraction of plasma samples
Descripción

Reclining, at least double-recurrent central venous catheters for administration of drugs and for the extraction of plasma samples

Tipo de datos

boolean

For patients of childbearing age: existence of a negative Pregnancy tests within 7 days prior to initiation of treatment and adequate contraception during study participation
Descripción

For patients of childbearing age: existence of a negative Pregnancy tests within 7 days prior to initiation of treatment and adequate contraception during study participation

Tipo de datos

boolean

Life expectancy ≥5 days
Descripción

Life expectancy ≥5 days

Tipo de datos

boolean

Treatment in one of said test centers
Descripción

Treatment in one of said test centers

Tipo de datos

boolean

Adequate renal and hepatic function in accordance with the following definitions
Descripción

Adequate renal and hepatic function in accordance with the following definitions

Tipo de datos

boolean

Bilirubin Total: ≤ 3x upper reference value
Descripción

Bilirubin Total: ≤ 3x upper reference value

Tipo de datos

boolean

SGOT or SGPT: ≤ 3x upper reference value
Descripción

SGOT or SGPT: ≤ 3x upper reference value

Tipo de datos

boolean

Alkaline phosphatase: ≤ 5x upper reference value
Descripción

Alkaline phosphatase: ≤ 5x upper reference value

Tipo de datos

boolean

Creatinine i. S.: ≤ 2x the upper reference value
Descripción

Creatinine i. S.: ≤ 2x the upper reference value

Tipo de datos

boolean

Written informed consent of the patient or the legal representative
Descripción

Written informed consent of the patient or the legal representative

Tipo de datos

boolean

Exclusion criteria
Descripción

Exclusion criteria

Alias
UMLS CUI-1
C0680251
Participate in this study at an earlier date
Descripción

Participate in this study at an earlier date

Tipo de datos

boolean

Serious psychiatric pre-/concomitant disease
Descripción

Serious psychiatric pre-/concomitant disease

Tipo de datos

boolean

Pregnancy or lactation
Descripción

Pregnancy or lactation

Tipo de datos

boolean

Women of childbearing age with insufficient or unsecured contraception
Descripción

Women of childbearing age with insufficient or unsecured contraception

Tipo de datos

boolean

Proof of probable or proven invasive active Fungal infection at the time of study inclusion (see EORTC / MSG-defi nition)
Descripción

Proof of probable or proven invasive active Fungal infection at the time of study inclusion (see EORTC / MSG-defi nition)

Tipo de datos

boolean

Patient with pathological function parameters of liver and kidney function
Descripción

Patient with pathological function parameters of liver and kidney function

Tipo de datos

boolean

Total bilirubin:> 3x upper reference value
Descripción

Total bilirubin:> 3x upper reference value

Tipo de datos

boolean

SGOT or SGPT:> 3x upper reference value
Descripción

SGOT or SGPT:> 3x upper reference value

Tipo de datos

boolean

Alkaline phosphatase:> 5x the upper reference value
Descripción

Alkaline phosphatase:> 5x the upper reference value

Tipo de datos

boolean

Creatinine i. S.:> 2x upper reference value
Descripción

Creatinine i. S.:> 2x upper reference value

Tipo de datos

boolean

Clinical and/or laboratory evidence of active veno-occlusive disease. VOD is characterized by an increase in serum transaminases and following a persistent increase in serum bilirubin and liver tenderness, weight gain and ascites
Descripción

Clinical and/or laboratory evidence of active veno-occlusive disease. VOD is characterized by an increase in serum transaminases and following a persistent increase in serum bilirubin and liver tenderness, weight gain and ascites

Tipo de datos

boolean

Hemodynamically instablier patient or patient with an anticipated Survival time of <5 days
Descripción

Hemodynamically instablier patient or patient with an anticipated Survival time of <5 days

Tipo de datos

boolean

Concomitant use of rifampicin, phenytoin, carbamazepine, phenobarbital, Dexamethasone, efavirenz and nevirapine
Descripción

Concomitant use of rifampicin, phenytoin, carbamazepine, phenobarbital, Dexamethasone, efavirenz and nevirapine

Tipo de datos

boolean

Patient with a history of intolerance to echinocandin antifungals or documented allergic reactions to amphotericin B
Descripción

Patient with a history of intolerance to echinocandin antifungals or documented allergic reactions to amphotericin B

Tipo de datos

boolean

Any other condition or circumstance, that in the opinion of the attending physician pose a risk for the patient, impair the protocol-compliant therapy of the patient, and could affect the objective of the study
Descripción

Any other condition or circumstance, that in the opinion of the attending physician pose a risk for the patient, impair the protocol-compliant therapy of the patient, and could affect the objective of the study

Tipo de datos

boolean

Missing or incomplete consent
Descripción

Missing or incomplete consent

Tipo de datos

boolean

Volver a la parte superior de la página

Similar models

Inclusion and exclusion criteria Stem-Cell Transplantation CASLAMB NCT00148148

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion criteria
C1512693 (UMLS CUI-1)
Adult Patient (≥ 18 years) with granulocytopenia (absolute number neutrophil: ≤500 / μl) and allogeneic hematopoietic condition after Stem cell transplantation and immunosuppression with cyclosporine A
Item
Adult Patient (>=18 years) with granulocytopenia (absolute number neutrophil: <=500 / ul) and allogeneic hematopoietic condition after Stem cell transplantation and immunosuppression with cyclosporine A
boolean
Patient with persistent or relapsed fever (oral temperature ≥38.0°C) and granulocytopenia (absolute Neutrophil Count ≤500 / μl) and adequate antibacterial therapy for ≥36-48 Hours in need of empirical antifungal therapy A
Item
Patient with persistent or relapsed fever (oral temperature ≥38.0°C) and granulocytopenia (absolute Neutrophil Count ≤500 / μl) and adequate antibacterial therapy for ≥36-48 Hours in need of empirical antifungal therapy A
boolean
Reclining, at least double-recurrent central venous catheters for administration of drugs and for the extraction of plasma samples
Item
Reclining, at least double-recurrent central venous catheters for administration of drugs and for the extraction of plasma samples
boolean
For patients of childbearing age: existence of a negative Pregnancy tests within 7 days prior to initiation of treatment and adequate contraception during study participation
Item
For patients of childbearing age: existence of a negative Pregnancy tests within 7 days prior to initiation of treatment and adequate contraception during study participation
boolean
Life expectancy ≥5 days
Item
Life expectancy ≥5 days
boolean
Treatment in one of said test centers
Item
Treatment in one of said test centers
boolean
Adequate renal and hepatic function in accordance with the following definitions
Item
Adequate renal and hepatic function in accordance with the following definitions
boolean
Bilirubin Total: ≤ 3x upper reference value
Item
Bilirubin Total: ≤ 3x upper reference value
boolean
SGOT or SGPT: ≤ 3x upper reference value
Item
SGOT or SGPT: ≤ 3x upper reference value
boolean
Alkaline phosphatase: ≤ 5x upper reference value
Item
Alkaline phosphatase: ≤ 5x upper reference value
boolean
Creatinine i. S.: ≤ 2x the upper reference value
Item
Creatinine i. S.: ≤ 2x the upper reference value
boolean
Written informed consent of the patient or the legal representative
Item
Written informed consent of the patient or the legal representative
boolean
Item Group
Exclusion criteria
C0680251 (UMLS CUI-1)
Participate in this study at an earlier date
Item
Participate in this study at an earlier date
boolean
Serious psychiatric pre-/concomitant disease
Item
Serious psychiatric pre-/concomitant disease
boolean
Pregnancy or lactation
Item
Pregnancy or lactation
boolean
Women of childbearing age with insufficient or unsecured contraception
Item
Women of childbearing age with insufficient or unsecured contraception
boolean
Proof of probable or proven invasive active Fungal infection at the time of study inclusion (see EORTC / MSG-defi nition)
Item
Proof of probable or proven invasive active Fungal infection at the time of study inclusion (see EORTC / MSG-defi nition)
boolean
Patient with pathological function parameters of liver and kidney function
Item
Patient with pathological function parameters of liver and kidney function
boolean
Total bilirubin:> 3x upper reference value
Item
Total bilirubin:> 3x upper reference value
boolean
SGOT or SGPT:> 3x upper reference value
Item
SGOT or SGPT:> 3x upper reference value
boolean
Alkaline phosphatase:> 5x the upper reference value
Item
Alkaline phosphatase:> 5x the upper reference value
boolean
Creatinine i. S.:> 2x upper reference value
Item
Creatinine i. S.:> 2x upper reference value
boolean
Clinical and/or laboratory evidence of active veno-occlusive disease. VOD is characterized by an increase in serum transaminases and following a persistent increase in serum bilirubin and liver tenderness, weight gain and ascites
Item
Clinical and/or laboratory evidence of active veno-occlusive disease. VOD is characterized by an increase in serum transaminases and following a persistent increase in serum bilirubin and liver tenderness, weight gain and ascites
boolean
Hemodynamically instablier patient or patient with an anticipated Survival time of <5 days
Item
Hemodynamically instablier patient or patient with an anticipated Survival time of <5 days
boolean
Concomitant use of rifampicin, phenytoin, carbamazepine, phenobarbital, Dexamethasone, efavirenz and nevirapine
Item
Concomitant use of rifampicin, phenytoin, carbamazepine, phenobarbital, Dexamethasone, efavirenz and nevirapine
boolean
Patient with a history of intolerance to echinocandin antifungals or documented allergic reactions to amphotericin B
Item
Patient with a history of intolerance to echinocandin antifungals or documented allergic reactions to amphotericin B
boolean
Any other condition or circumstance, that in the opinion of the attending physician pose a risk for the patient, impair the protocol-compliant therapy of the patient, and could affect the objective of the study
Item
Any other condition or circumstance, that in the opinion of the attending physician pose a risk for the patient, impair the protocol-compliant therapy of the patient, and could affect the objective of the study
boolean
Missing or incomplete consent
Item
Missing or incomplete consent
boolean
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial